Modified sarcosine oxidase, process for producing the same and reagent composition using the same
A technology for sarcosine oxidase and sarcosine oxidase activity, which is applied in the field of sarcosine oxidase and can solve problems such as the unclear role of the original substrate creatine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0113] Example 1. Construction of a plasmid expressing sarcosine oxidase
[0114] Expression plasmid pSAOEP3 for expression of sarcosine oxidase derived from Arthrobacter sp. TE1826 strain was constructed by the method described in JP-7-163341-A. This expression plasmid has an approximately 1.7 kbp DNA insert containing the gene encoding the sarcosine oxidase of TE1826 at the multiple cloning site of pUC18. Its nucleotide sequence is shown in SEQ ID NO:2, and the amino acid sequence of sarcosine oxidase deduced from the nucleotide sequence is shown in SEQ ID NO:1.
Embodiment 2A
[0115] Example 2A. Preparation of modified sarcosine oxidase gene
[0116] The preparation method of the recombinant plasmid (pSAOM1A) of the modified sarcosine oxidase that encodes 89 lysines replaced by arginine in the amino acid sequence of SEQ ID NO: is to use the expression plasmid pSAOEP3 containing the sarcosine oxidase gene and Synthetic oligonucleotide of SEQ ID NO: 3 and its synthetic complementary oligonucleotide using QuickChange TM The site-directed mutation kit (provided by Stratagen) was operated according to the procedure, followed by sequencing.
[0117] The preparation method of the recombinant plasmid (pSAOM2A) of the modified sarcosine oxidase encoding the 155th cysteine in the amino acid sequence of 1 replaced by isoleucine (pSAOM2A) is to use pSAOEP3 and the synthetic oligo of SEQ ID NO: 4 Nucleotides and their synthetic complementary oligonucleotides, using QuickChange TM Site-directed mutagenesis kit (provided by Stratagen), and operated in the sa...
Embodiment 3A
[0129] Example 3A. Preparation of modified sarcosine oxidase
[0130] Transform Escherichia coli JM109 competent cells with the following recombinant plasmids pSAOM1A, pSAOM2A, pSAOM3A, pSAOM4A, pSAOM5A, pSAOM6A, pSAOM7A, pSAOM8A, pSAOM9A, pSAOM10A, pSAOM11A, pSAOM12A and pSAOM13A to obtain transformants.
[0131] Put 400 mL of Terrific nutrient solution in a 2L Sakaguchi flask, sterilize at 121°C for 20 minutes, cool, and then add separately sterilized and filtered ampicillin at a final concentration of 100 μg / mL. The culture solution (5 mL) of Escherichia coli JM109 (pSAOM1A) previously cultured in LB medium containing 100 μg / mL ampicillin at 30° C. for 16 hours was inoculated into the above-mentioned medium, and cultured with shaking at 30° C. for 20 hours with aeration. After the end of the culture, the sarcosine oxidase activity in the above-mentioned activity measurement was about 9.5 U / mL of the culture solution.
[0132] The above-mentioned bacterial cells were coll...
PUM
Property | Measurement | Unit |
---|---|---|
Km value | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com